Bio-Path Holdings Inc. (BPTH) Plunges 14.68% on March 20

Equities Staff  |

Bio-Path Holdings Inc. (BPTH) had a rough trading day for Wednesday March 20 as shares tumbled 14.68%, or a loss of $-3.7 per share, to close at $21.50. After opening the day at $24.75, shares of Bio-Path Holdings Inc. traded as high as $24.75 and as low as $21.30. Volume was 1.05 million shares over 6,811 trades, against an average daily volume of n/a shares and a total float of 2.51 million.

As a result of the decline, Bio-Path Holdings Inc. now has a market cap of $53.91 million. In the last year, shares of Bio-Path Holdings Inc. have traded between a range of $73.52 and $1.61, and its 50-day SMA is currently $n/a and 200-day SMA is $n/a.

For a complete fundamental analysis of Bio-Path Holdings Inc., check out Equities.com’s Stock Valuation Analysis report for BPTH.

Still paying commissions on stock trades? Equities.com now offers $7.99/month unlimited trading and flat-fee options trading for $89.99/month! Get started today by https://www.equities.com/trading-start

Bio-Path Holdings Inc is a US-based clinical and preclinical stage company. It focuses on oncology antisense drug development utilizing a novel technology. The company's drug delivery and antisense technology referred as DNAbilize, a platform that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification that is intended to protect the DNA from destruction by enzymes when circulating in vivo, incorporated inside of a neutrally charged lipid bilayer. The lead drug candidate of the company is prexigebersen which is a nonproprietary drug for acute myeloid leukemia as well as solid tumors, including breast cancer and ovarian cancer. Its other drug candidate is Liposomal Bcl2 which targets the protein Bcl2, which is responsible for driving cell proliferation of all cancers.

Bio-Path Holdings Inc. is based out of Bellaire, TX and has some 9 employees. Its CEO is Peter H. Nielsen.

Bio-Path Holdings Inc. is a component of the Russell 2000. The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

To get more information on Bio-Path Holdings Inc. and to follow the company’s latest updates, you can visit the company’s profile page here: BPTH’s Profile. For more news on the financial markets and emerging growth companies, be sure to visit Equities.com’s Newsdesk. Also, don’t forget to sign-up for our daily email newsletter to ensure you don’t miss out on any of our best stories.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.



DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Watchlist

Symbol Last Price Change % Change
AAPL

     
AMZN

     
HD

     
JPM

     
IBM

     
BA

     
WMT

     
DIS

     
XOM

     

World Economic Forum at Davos 2019 - Dominic Briggs General Partner Blockwall Management

Matt Bird sits down with Dominic Briggs, General Partner Blockwall Management at the World Economic Forum at Davos 2019